The first week of November was Medical Cannabis Awareness Week, prompting an excellent time for Volteface to reflect on the past three years since medical cannabis was legalised. In this piece we have caught up with Carly Barton, patient advocate and visionary behind Cancard, regarding the current climate for medical cannabis patients, as well as … Continued
It has been exactly 3 years since the UK legalised cannabis for medical use. However, few advocates are truly satisfied, with many campaigners continuing to call on the government to make further legislative changes to the existing legal framework. Such frustrations are easy to understand, especially when they involve the plight of young children … Continued
Medical Cannabis Awareness Week kicked off on Monday, marking three years since cannabis was legalised for medical purposes. On the 1st of November 2018 the Home Office amended cannabis as a schedule II under the Misuse Of Drug Act, allowing for specialist consultants to prescribe it for a wide range of conditions. However, since the … Continued
The federal election of Germany is on Sunday the 26th September, and its results will be pivotal to the state of cannabis policy reform both within the country, and across Europe. Promises pertaining to cannabis policy reform have been present in four out of the six major parties in Germany’s campaigns, ranging from decriminalisation to … Continued
The announcement of a partnership between Clerkenwell Health and Octarine Bio signals a momentous time for the growth and development of the European psychedelic ecosystem. This exciting partnership between these innovative startups aims to advance patient access to psychedelic treatments in Europe, and improve the quality of the psychedelic medicines produced in Europe. Clerkenwell Health … Continued
Leading medical cannabis provider Grow Group Plc has been raising on the crowdfunding platform Seedrs throughout August. So far they’ve had over 500 new investors invest in their company. Grow created the campaign to seek investment from ‘socially conscious shareholders’ in order to expand operations and hire new staff, attempting to expand the 1,200 medical … Continued
The Heroic Hearts Project UK (HHPUK) have this week announced a world-first observational study on the psychological and physiological effects of psilocybin on veterans with traumatic brain injury. HHPUK will partner with Imperial College London to provide veterans with a unique legal pathway to psychedelic-assisted therapy through a retreat in the Netherlands from August 2021; … Continued
This week Charlotte Caldwell, mother of Billy – the boy who changed the law, announced the launch of the I am Billy campaign. This groundbreaking campaign is asking for the Government’s support in taking crucial steps towards improving patients’ access to cannabis medicines prescribed by the NHS. Following the success of previous campaigning efforts … Continued
This week the London Mayor’s race erupted around a question that is bound to delight drug reformers – cannabis reform in the capital. Whilst the naysayers are crying electoral point-scoring on both sides across the echo chambers of Twitter, groups like Volteface have been busy behind the scenes engineering an environment that is ripe … Continued
A recent literature review by PhytoSciences Ghana has provided a summary of the preclinical evidence for the medicinal use of cannabinoids as an alternative treatment for mental health disorders. In light of these conclusions we have interviewed a patient who uses medicinal cannabis to manage ADHD and OCD, to explore how the findings of … Continued